Search Results

Appendix 6b- Communication Agreement for Formal Investigations.docx

Disclosure Ref 2024159 - Urinary Cathetar .pdf

Disclosure Ref 202596 - Diagnosis of Essential Tremor.pdf

FOI Disclosure Ref 202596 - number of patients that were diagnosed with Essential Tremor across DCHS

Disclosure Ref 2025134 - Formaldehyde levels.pdf

FOI disclosure ref 202134 regarding number of formaldehyde levels recorded in the Trust’s Histopathology Department

Disclosure Ref 2024172 - Electric, gas, fuel & water meters in the organisation's buildings.pdf

Homely Remedies SOP (S16)

Under normal circumstances, medicines should be administered either on the written prescription of an authorised prescriber, in accordance with the Medicines Code or under the authority of a Patient Group Direction. The Medication Optimisation Safety Team (MOST) has approved a list of non-prescription medicines or “homely remedies” that registered nurses and registered practitioners are authorised to administer at their own discretion, in accordance with the attached standard operating procedure, for a maximum of 48 hours (extended to 72 hours over a bank holiday weekend). The homely remedies approved are treatments commonly available over the counter for minor, short-term conditions without the need for a prescription or Patient Group Direction.

Controlled Drugs SOP for Community Hospitals (S47)

This series of Standard Operating Procedures ensures that all processes involving Controlled Drugs (CDs) carried out in Wards and Departments of Community Hospitals are conducted in strict accordance with current statutory requirements that adequate records are maintained and a robust audit trail exists. This includes security, ordering, receipt, administration, issue, balance checking, and return or destruction.

Disclosure Ref 202219 - Roles and banding as at Jan 2022 - Copy.pdf

FOI Disclosure

HRP29 Registration Re-Registration and Revalidation Manager's Guide.docx

Appendix 10: Blood bikes information

Appendix 10: Blood bikes information, for clinicians - Section 5.28 Covid 19 IP&C Policy